Insights

Where we share all our thoughts, ideas and views.

Filter by:
Impact of Brexit on Marketing Authorisations and Regulatory Affairs

Impact of Brexit on Marketing Authorisations and Regulatory Affairs

Given the highly regulated nature of the Pharmaceutical and Life Sciences sector, it’s no surprise that the separation of the UK from the EU could have major ramifications for the industry. For many organisations in the sector, the future arrangements for regulation of medicines and medical devices post-Brexit is the main concern in their preparations for operating Beyond Brexit.

Start adding items to your reading lists:
or
Save this item to:
This item has been saved to your reading list.
How Brexit may impact patients’ access to novel therapies

How Brexit may impact patients’ access to novel therapies

Beyond transferring licences in preparation for Brexit, companies should now be asking what the future looks like for the UK and EU regulatory landscape and how this might impact strategic decision making (i.e. clinical trial locations and product launches). The future landscape is dependent on the level of divergence of the MHRA from the EMA and the industry’s interpretation of the implications of any divergence.

Start adding items to your reading lists:
or
Save this item to:
This item has been saved to your reading list.
Connected Home 2.0

Connected Home 2.0

Nearly two years after our first Connected Homes research, how have consumer attitudes, beliefs and intentions changed towards the growing smart home technology market? We set out to discover whether recent innovations have transformed the way they engage with their homes, or if consumers are still not convinced on the benefits of the Connected Home.

Start adding items to your reading lists:
or
Save this item to:
This item has been saved to your reading list.
Follow us: